ig-about

About Us

Located in Lisbon (Portugal), Vidara Pharma is responsible for:

  • API co-developments
  • Supply high-quality pharmaceuticals
  • Provide a broad range of services on a global scale
  • Count on a partner network of modern logistics centers and warehouses worldwide, which allows us to provide fast and efficient services.

OUR LATEST ACHIEVEMENTS

2024

API Own Development. 
Ofichem as CDMO for​ the development and manufacturing of Almotriptan.​​​

2023

API Own Development.
Ofichem as CDMO for​ the development and manufacturing of​ Etofenamate​.

2023

API Co-development with a new partner for the development and manufacturing of​ Noradrenaline​.

2022

API Co-development with Chr. Olesen Synthesis for the development and manufacturing of Apomorphine​​​.

2021

API Co-development with Lebsa for the development, manufacturing and distribution of Octenidine​.​​​

2020

Launch of our customer portal, which provides you with real-time information at your fingertips.

2008

HELM becomes the CEP holder for Heparin Sodium manufactured by Changzhou Quianhong Bio Pharma Co., Ltd​.​

2007

Exclusive distribution agreement with CSPC Weisheng Ph. Co Ltd. for distribution of pharma grade Ascorbid Acid and derivatives​​​.

Behind the world’s leading Pharmaceuticals

VIDARA PHARMA DEVELOPS APIs FOR YOU

Vidara Pharma co-develops APIs together with European manufacturers, allowing you to have access to the right APIs.

About_us_-_molecule

Increase your portfolio

About_us_-_security

Mitigate risks

About_us_-_stopwatch

Shorten your lead times

ACCESS TO THE RIGHT APIs

As a virtual API manufacturer, we have the flexibility to choose the best partner and state-of-the-art technology according to each API.

About_us_-_hand-shake

+25 years of experience in product development.

About_us_-_red-flag

Worldwide network developed over decades.

About_us_-_worldwide_network

Our Market Intelligence and Portfolio teams allow us to make a full assessment of the best APIs.

About_us_-_market_intelligence